MedPath

Broadband Amplification as Tinnitus Treatment

Not Applicable
Completed
Conditions
Tinnitus, Subjective
Interventions
Device: Broadband amplification from hearing aids
Device: Band-limited amplification from hearing aids
Registration Number
NCT05271825
Lead Sponsor
Technical University of Denmark
Brief Summary

* The effect of broadband amplification was tested in a double-blinded crossover study

* Its effect was compared to an active placebo treatment

* An improvement in tinnitus distress was found after use of broadband amplification

* No effect was found on the tinnitus loudness

Detailed Description

This study investigated the effect of broadband amplification (125 Hz to 10 kHz) as tinnitus treatment for participants with high-frequency hearing loss and compared these effects with an active placebo condition using band-limited amplification (125 Hz to 3-4 kHz). A double-blinded crossover study. 23 participants with a high-frequency (≥ 3 kHz) hearing loss and chronic tinnitus were included in the study and 17 completed the full treatment protocol. Two different hearing aid treatments were provided for 3 months each: broadband amplification that provided gain in the frequency range from 125 Hz to 10 kHz and band-limited amplification that only provided gain in the low frequency range (≤ 3-4 kHz). The effect of the two treatments on tinnitus distress was evaluated with the Tinnitus Handicap Inventory (THI) and the Tinnitus Functional Index (TFI) questionnaires. The effect of the treatment on tinnitus loudness was evaluated with a visual analog scale (VAS) for loudness and a psychoacoustic loudness measure. Furthermore, the tinnitus annoyance was evaluated with a VAS for annoyance. The tinnitus pitch was evaluated based on the tinnitus likeness spectrum.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • Chronic tinnitus
  • hearing thresholds (<=25 dB HL) up to 2000 Hz and hearing loss at frequencies above 2 kHz
  • inexperienced hearing aid user
Exclusion Criteria
  • objective or pulsatile tinnitus
  • Ménière's disease, otosclerosis, stapedectomy, stapedotomy or tympanoplasty

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Broadband amplificationBroadband amplification from hearing aidsbroadband amplification: (125 Hz to 10 kHz)
Band-limited amplificationBand-limited amplification from hearing aidsband-limited amplification (125 Hz to 3-4 kHz)
Primary Outcome Measures
NameTimeMethod
Tinnitus Handicap Inventory3 months

Questionnaire assessing tinnitus related distress. 25 questions that can be answered with yes(4 points), sometimes (2 points), no (0 points)

Tinnitus Functional Index3 months

Questionnaire assessing tinnitus related distress. 25 questions that can be answered with likert scale from 0-10 (or 0-100%) where 10 is the most extreme negative value

Secondary Outcome Measures
NameTimeMethod
Visual Analog Scale - annoyance3 months

Likert scale from 0-10 where 0 = "My tinnitus is not annoying" and 10 = "My tinnitus is extremely annoying"

Visual Analog Scale - loudness3 months

Likert scale from 0-10 where 0 = "I cannot hear my tinnitus" and 10 = "My tinnitus is extremely loud"

Tinnitus loudness3 months

Psychoacoustic measurement. Participants are asked to match the loudness of their tinnitus to either a pure-tone or noisy sound. The loudness of the matched tone could be changed in 3 decibel steps.

Tinnitus spectrum3 months

The tinnitus spectrum rating method was adapted from Noreña et al. (2002). As the stimuli, either 2-s long pure tones (1st condition) or 2-s long 1/3-octave noise bands (2nd condition) with center frequencies ranging from 125 Hz to 14 kHz were used. The stimuli were presented monaurally via headphones to the ear corresponding to the loudest tinnitus perception. In case the tinnitus percept was the same in both ears, the stimuli were presented to the ear with the lowest average high-frequency thresholds. All stimuli were presented at the level matched to the tinnitus loudness for a 1 kHz pure tone, but always at or above 10 dB sensation level (SL).

Trial Locations

Locations (1)

Technical University of Denmark

🇩🇰

Kongens Lyngby, Denmark

© Copyright 2025. All Rights Reserved by MedPath